Clinical Trial Update: Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether pentoxifylline can protect against doxorubicin-induced cardiotoxicity in breast cancer patients; recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Doxorubicin-induced Cardiotoxicity

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Tanta University | Conditions: Doxorubicin Induced Cardiotoxicity, Breast Cancer | Phase 2 | Status: RECRUITING